Kosco-Vilbois, Marie,Leger, Olivier,Fischer, Nicolas
申请号:
AU2008219570
公开号:
AU2008219570B2
申请日:
2008.02.28
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The invention relates to fully human antibodies, and fragments thereof, thatbind to interferon-inducible-protein-10 (IP-IO, CXCLlO), thereby modulatingthe interaction between IP-IO and its receptor, CXCR3, and/or modulating thebiological activities of IP-IO. The invention also relates to the use of suchanti-IP- 10 antibodies in the prevention or treatment of immune-related disordersand in the amelioration of one or more symptoms associated with an immune-relateddisorder.